C. Erem Et Al. , "Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism," ENDOCRINE , vol.36, no.3, pp.473-478, 2009
Erem, C. Et Al. 2009. Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. ENDOCRINE , vol.36, no.3 , 473-478.
Erem, C., ÜÇÜNCÜ, Ö., YILMAZ, M., KOÇAK, M., NUHOĞLU, İ., & Ersoz, H. O., (2009). Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism. ENDOCRINE , vol.36, no.3, 473-478.
Erem, CİHANGİR Et Al. "Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism," ENDOCRINE , vol.36, no.3, 473-478, 2009
Erem, CİHANGİR Et Al. "Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism." ENDOCRINE , vol.36, no.3, pp.473-478, 2009
Erem, C. Et Al. (2009) . "Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism." ENDOCRINE , vol.36, no.3, pp.473-478.
@article{article, author={CİHANGİR EREM Et Al. }, title={Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hyperthyroidism}, journal={ENDOCRINE}, year=2009, pages={473-478} }